Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

797
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
797
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

844
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
844
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.5K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Liver Regeneration01:24

Liver Regeneration

4.5K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.5K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

298
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
298

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Making space and opportunities for talent to grow.

JHEP reports : innovation in hepatology·2026
Same author

Brain health awareness among solid organ transplant candidates and recipients: a single centre survey.

BMC neurology·2026
Same author

A novel activating somatic mutation in EPAS1, coding for HIF-2α, in a patient with a paraganglioma and sickle cell disease.

Archives of endocrinology and metabolism·2026
Same author

An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis.

Clinical and experimental immunology·2026
Same author

Thyroid function and liver fibrosis: FT3 levels are inversely and independently correlated with enhanced liver fibrosis score in solid organ transplant patients with dysglycemia.

Frontiers in immunology·2026
Same author

iRhom2 regulates HMGB1 secretion to modulate inflammation and hepatocyte senescence in an in vitro model of ischemia-reperfusion injury.

Cell death & disease·2026

Related Experiment Video

Updated: Feb 25, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

54.8K

Pathogenesis of biliary fibrosis.

Massimo Pinzani1, Tu Vinh Luong2

  • 1UCL Institute for Liver and Digestive Health, London NW3 2QG, United Kingdom.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
|July 30, 2017
PubMed
Summary

Chronic liver diseases like primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) cause fibrosis. Pure cholestasis without inflammation doesn't significantly drive liver fibrosis, unlike bile duct damage.

Keywords:
CholestasisPBCPSCliver fibrosis

More Related Videos

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

3.3K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

17.8K

Related Experiment Videos

Last Updated: Feb 25, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

54.8K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

3.3K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

17.8K

Area of Science:

  • Hepatology
  • Fibrosis Research
  • Cholestasis Pathophysiology

Background:

  • Chronic cholestatic liver diseases, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), are linked to hepatic fibrogenesis and cirrhosis.
  • The exact relationship between cholestasis and liver fibrosis remains unclear.
  • Fibrogenesis is a dynamic process influenced by the extent and duration of liver injury, such as viral or alcohol-induced hepatocellular necrosis.

Purpose of the Study:

  • To clarify the relationship between cholestasis and liver tissue fibrosis.
  • To differentiate the fibrogenic potential of pure cholestasis versus cholestasis with inflammation and bile duct damage.

Main Methods:

  • Review of existing literature on cholestatic liver diseases and fibrosis.
  • Analysis of the mechanisms underlying fibrogenesis in different cholestatic conditions.
  • Comparison of fibrotic progression in "pure" cholestasis versus cholestasis with bile duct injury.

Main Results:

  • "Pure" intrahepatic cholestasis, without hepatocellular damage or inflammation, is not associated with significant liver fibrosis.
  • Marked and progressive liver fibrosis consistently follows diseases with chronic inflammatory bile duct damage (e.g., PBC, PSC) or biliary obstruction.
  • Fibrogenesis in these conditions involves complex interactions between immune/inflammatory pathways, cytokines, and cell homeostasis.

Conclusions:

  • Inflammatory bile duct damage is a key driver of progressive liver fibrosis in cholestatic diseases.
  • Understanding these fibrogenic mechanisms is essential for identifying new diagnostic and therapeutic targets.
  • The nature and extent of liver injury, particularly bile duct involvement, dictate the fibrotic response in cholestasis.